• Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

4563:JP

361.0 JPY 12.0 3.22%

As of 22:11:38 ET on 07/29/2014.

Snapshot for AnGes MG Inc (4563)

Open: 367.0 Day's Range: 358.0 - 369.0 Volume: 219,400
Previous Close: 373.0 52wk Range: 279.8 - 1,143.7 1-Yr Rtn: -65.16%

Stock Chart for 4563

No chart data available.
  • 4563:JP 361.0
  • 1D
  • 1M
  • 1Y
373.0
Interactive 4563 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4563

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. TPX -
Earnings Per Share (JPY) (ttm) -40.5118
Est. EPS (JPY) (12/2014) -67.8300
Est. PEG Ratio -
Market Cap (M JPY) 23,460.42
Shares Outstanding (M) 64.81
30 Day Average Volume 716,909
Price/Book (mrq) 4.2904
Price/Sale (ttm) 29.2494
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4563

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4563

AnGes MG, Inc. develops gene-therapy drugs that use Hepatocyte Growth Factor (HGF) for myocardial infarction and arteriosclerosis patients. The Company also develops nucleic acid drug (decoy oligo) for patients with asthma, allergy, and rheumatism. AnGes MG develops vectors (a carrier used to introduce a foreign gene into a host cell) which help study and analyze genetic functions.

Ei YamadaPresident/CEOShunsuke SamiExecutive Vice President
Makoto SekiExecutive OfficerTakahiro NakazawaExecutive Officer
More Company Profile & Key Executives for 4563

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil